Salix Expands Product Portfolio through Merck & Co. Licensing Deal
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 82 (Table of Contents)
Published: 7 Apr-2007
DOI: 10.3833/pdr.v2007.i82.363 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Salix Pharmaceuticals has in-licensed the US rights for two products Pepcid® and Diuril® from Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS